A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid | MicrobiomeTrials← Back to trialsNCT04206553
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
CompletedPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2020-10-28Est. Completion: 2024-07-12
Enrollment target: 106 participants Locations- Regeneron study Site, Birmingham, Alabama, United States
- Regeneron Study Site, Scottsdale, Arizona, United States
- Regeneron Study Site, Redwood City, California, United States
- Regeneron Study Site, Farmington, Connecticut, United States
- Regeneron Study Site, Miami, Florida, United States
- Regeneron study Site, Orlando, Florida, United States
- Regeneron Study Site, Iowa City, Iowa, United States
- Regeneron Study Site, Boston, Massachusetts, United States
- Regeneron study Site, Ann Arbor, Michigan, United States
- Regeneron Study Site, Chapel Hill, North Carolina, United States
- Regeneron Study Site, Portland, Oregon, United States
- Regeneron Study Site, Philadelphia, Pennsylvania, United States
- Regeneron study Site, Providence, Rhode Island, United States
- Regeneron Study Site, Murray, Utah, United States
- Regeneron study Site, Charlottesville, Virginia, United States
- Regeneron Study Site, Kogarah, New South Wales, Australia
- Regeneron Study Site, Box Hill, Victoria, Australia
Other microbiome trials you might be interested in
Bullous Pemphigoid (BP)
Bullous pemphigoid is an autoimmune subepidermal blistering disease characterized by eosinophilic inflammation and varia…
Istanbul, Turkey (Türkiye)Est. completion Dec 24, 2026
OsteoporosisBullous Pemphigoid
Bullous pemphigoid is the most common type of bullous skin disease and is clinically characterized by clear-tense bullae…
Amiens, FranceCompleted Oct 22, 2025
Regeneron Study Site, Bobigny, FranceRegeneron Study Site, Bordeaux, FranceRegeneron Study Site, Lille, FranceRegeneron Study Site, Nice, FranceRegeneron Study Site, Paris, FranceRegeneron Study Site, Rouen, FranceRegeneron Study Site, Münster, North Rhine-Westphal, GermanyRegeneron Study Site, Mainz, Rhineland-Palatinate, GermanyRegeneron Study Site 2, Dresden, Saxony, GermanyRegeneron Study Site, Lübeck, Schleswig-Holstein, GermanyRegeneron Study Site, Berlin, GermanyRegeneron Study Site, Buxtehude, GermanyRegeneron Study Site, Erlangen, GermanyRegeneron Study Site, Freiburg im Breisgau, GermanyRegeneron Study site', Magdeburg, GermanyRegeneron Study site, Marburg, GermanyRegeneron Study Site, Munich, GermanyRegeneron Study Site, Stuttgart, GermanyRegeneron study Site, Afula, IsraelRegeneron study Site, Petah Tikva, IsraelRegeneron study Site, Tel Aviv, IsraelRegeneron Study site, Kurume, Hukuoka, JapanRegeneron Study Site, Hirosaki, JapanRegeneron Study Site, Ichinomiya, JapanRegeneron Study Site, Osaka, JapanRegeneron Study Site, Sapporo, JapanRegeneron Study Site, Tokyo, JapanRegeneron Study Site, Krakow, Lesser Poland Voivodeship, PolandRegeneron Study site', Ossy, PolandRegeneron Study site', Wroclaw, PolandRegeneron Study Site, Badalona, Barcelona, SpainRegeneron Study Site, Madrid, SpainRegeneron study Site, Madrid, SpainRegeneron study Site, Pamplona, SpainRegeneron study Site, Taipei, Zhongzheng District, TaiwanRegeneron study Site, Taoyuan City, Taiwan